LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches

Contributed by: PR Newswire

Tags

LTS-Lohmann-Therapie

More Like This

LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches

First product based on LTS Sorrel™ wearable drug delivery platform launched in the US

PR Newswire associated0

Daewoong Pharmaceutical to Initiate Clinical Trials Early Next Year for Innovative 'GLP-1 Obesity Treatment' with Advanced Microneedle Technology for Sustained Weekly Efficacy

LifeArc makes multi-million pound investment to support drug discovery in sub-Saharan Africa

L&T Technology Services Collaborates With NVIDIA to Unveil Gen AI and Advanced Software-Defined Architecture for Medical Devices

PR Newswire associated0

MTD Group completes the acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring Systems and announces a significant investment plan for its European production sites

Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned

Global donors pledge over US$777 million to defeat neglected tropical diseases and improve the lives of 1.6 billion people at the Reaching the Last Mile Forum at COP28